“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors”. Journal of Kidney Cancer, vol. 12, no. 2, May 2025, pp. 37-45, https://doi.org/10.15586/jkcvhl.v12i2.386.